OCT macular changes in type 1 ROP following Ranibizumab injections
Ranibizumab treated eyes in type 1 show ORL thickening and differentiation but with inadequate resolution of ME.
Authors
- Jylan Gouda (ORCID: https://orcid.org/0000-0001-5868-5055)
- Ayman M. Khattab (ORCID: https://orcid.org/0000-0002-3246-3136)
- Abdussalam M. Abdullatif (ORCID: https://orcid.org/0000-0001-7273-5311)
- Tamer A. Macky (ORCID: https://orcid.org/0000-0002-9767-8912)
- Rawan Hosny (ORCID: https://orcid.org/0009-0001-2852-5007)
- Hany Mekkawy
Institutions
- Cairo University (EG)
Publication Details
- Journal
- International Journal of Retina and Vitreous
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1186/s40942-025-00664-7
- Primary Topic
- Retinopathy of Prematurity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cairo University
- Science and Technology Development Fund